Click to search for your profile
Click to search for condition or expert
Click to open main menu
Save Condition
Bookmark
Share
Share
Condition
Clinical Trials for
Chromophobe Renal Cell Carcinoma
Overview
Find a Doctor
Latest Advances
Clinical Trials
Clinical Trials
Search for trials
Filter
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 2
Intervention Type:
Drug
Participants:
21
Start Date:
June 1, 2021
A Phase 2 Study of Pamiparib (BGB-290) Plus Temozolomide for Hereditary Leiomyomatosis and Renal Cell Cancer (HLRCC)
Clinical Trial
Status:
Not yet recruiting
Participants:
90
Start Date:
March 1, 2021
Evaluating the Bacterial and Fungal Microbiome in Patients With Calcium Oxalate Urolithiasis and Renal Cell Carcinoma.
Search for trials
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Drug
Participants:
40
Start Date:
March 2021
A Phase I/IB Trial of Abemaciclib Alone or in Combination With MK-6482 in Advanced Renal Cell Carcinoma
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Other
Participants:
30
Start Date:
February 20, 2021
E-Interventions to Treat Fear of Cancer Recurrence for Patients With Localized Renal Cell Carcinoma
Clinical Trial
Status:
Not yet recruiting
Phase:
Phase 1
Intervention Type:
Radiation, Drug
Participants:
50
Start Date:
February 2021
Phase I Study Investigating the Safety of Stereotactic Body Radiotherapy (SBRT) With Anti-PD1 and Anti-IL-8 for the Treatment of Multiple Metastases in Advanced Solid Tumors
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Other, Procedure, Radiation
Participants:
40
Start Date:
January 15, 2021
Cryoablation Combined With Stereotactic Body Radiation Therapy for the Treatment of Painful Bone Metastases
Clinical Trial
Status:
Not yet recruiting
Intervention Type:
Drug, Radiation
Participants:
135
Start Date:
January 2021
Multimodal PET/MRI Machine Learning Approaches for Characterization of Solid Tumors
Clinical Trial
Status:
Not yet recruiting
Phase:
N/A
Intervention Type:
Behavioral
Participants:
100
Start Date:
January 1, 2021
Impact of Telemonitoring for the Management of Side Effects in Patients With Melanoma, Lung or Renal Cancer, Treated With Immunotherapy Combination of Nivolumab and Ipilimumab.
Clinical Trial
Status:
Recruiting
Phase:
N/A
Intervention Type:
Diagnostic Test, Device
Participants:
20
Start Date:
December 5, 2020
Early Therapeutic Monitoring of Response to Therapy With Serial Ultrasound in Metastatic Renal Cell Carcinoma (mRCC)
Clinical Trial
Status:
Recruiting
Phase:
Phase 3
Intervention Type:
Drug, Procedure
Participants:
364
Start Date:
November 16, 2020
Phase III Trial of Immunotherapy-Based Combination Therapy With or Without Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma (PROBE Trial)
Clinical Trial
Status:
Recruiting
Phase:
Phase 2
Intervention Type:
Drug, Procedure, Biological
Participants:
84
Start Date:
November 13, 2020
A Phase II Study of Perioperative Pembrolizumab-Based Therapy in Patients With Locally Advanced or Metastatic Renal Cell Carcinoma Prior to Cytoreductive Nephrectomy or Metastasectomy
Clinical Trial
Status:
Recruiting
Phase:
Phase 1
Intervention Type:
Drug, Biological
Participants:
24
Start Date:
November 11, 2020
A Phase 1 Study to Evaluate the Safety, Proliferation and Persistence of GEN-011, an Autologous Adoptive Cell Therapy Targeting Neoantigens in Solid Tumors
Showing 1-12 of 131
Next